title: Keratinocyte Dystrophy as a Marker of Low-Dose Methotrexate-Induced Skin Toxicity: Comment on the Clinical Image by Mönch et al.
authors.affiliation: AP-HP, Hôpital Henri Mondor.
authors.forename: Julie
authors.initials: J
authors.lastname: Delyon
authors.affiliation: AP-HP, Hôpital Henri Mondor.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Ortonne
authors.affiliation: AP-HP, Hôpital Henri Mondor, INSERM Centre d'Investigation Clinique 006 and Université Paris Est-Créteil Val de Marne, Créteil, France.
authors.forename: Emilie
authors.initials: E
authors.lastname: Sbidian
authors.affiliation: AP-HP, Hôpital Henri Mondor, INSERM Centre d'Investigation Clinique 006 and Université Paris Est-Créteil Val de Marne, Créteil, France.
authors.forename: Olivier
authors.initials: O
authors.lastname: Chosidow
mesh_terms: D001172:Arthritis, Rheumatoid; D015415:Biomarkers; D006801:Humans; D015603:Keratinocytes; D008727:Methotrexate; D012867:Skin
chemical_list: D015415:Biomarkers; D008727:Methotrexate